These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11470554)

  • 1. Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
    Hyde TM; Crook JM
    J Chem Neuroanat; 2001 Jul; 22(1-2):53-63. PubMed ID: 11470554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic circuits and signaling in the pathophysiology of schizophrenia.
    Berman JA; Talmage DA; Role LW
    Int Rev Neurobiol; 2007; 78():193-223. PubMed ID: 17349862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective immunolesioning of cholinergic neurons in nucleus basalis magnocellularis impairs prepulse inhibition of acoustic startle.
    Ballmaier M; Casamenti F; Zoli M; Pepeu G; Spano P
    Neuroscience; 2001; 108(2):299-305. PubMed ID: 11734362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release.
    Berlanga ML; Simpson TK; Alcantara AA
    J Comp Neurol; 2005 Nov; 492(1):34-49. PubMed ID: 16175554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat.
    Alcantara AA; Chen V; Herring BE; Mendenhall JM; Berlanga ML
    Brain Res; 2003 Oct; 986(1-2):22-9. PubMed ID: 12965226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic dysfunction in schizophrenia.
    Yin DM; Chen YJ; Sathyamurthy A; Xiong WC; Mei L
    Adv Exp Med Biol; 2012; 970():493-516. PubMed ID: 22351070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a neuro-cognitive animal model of the cognitive symptoms of schizophrenia: disruption of cortical cholinergic neurotransmission following repeated amphetamine exposure in attentional task-performing, but not non-performing, rats.
    Kozak R; Martinez V; Young D; Brown H; Bruno JP; Sarter M
    Neuropsychopharmacology; 2007 Oct; 32(10):2074-86. PubMed ID: 17299502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating schizophrenia: novel targets for the cholinergic system.
    Money TT; Scarr E; Udawela M; Gibbons AS; Jeon WJ; Seo MS; Dean B
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):241-56. PubMed ID: 20053170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of the Functional Interaction between Brain Cholinergic and Dopaminergic Systems in the Pathogenesis and Treatment of Schizophrenia and Parkinson's Disease.
    Acharya S; Kim KM
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33919025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical cholinergic transmission and cortical information processing in schizophrenia.
    Sarter M; Nelson CL; Bruno JP
    Schizophr Bull; 2005 Jan; 31(1):117-38. PubMed ID: 15888431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attention and the Cholinergic System: Relevance to Schizophrenia.
    Lustig C; Sarter M
    Curr Top Behav Neurosci; 2016; 28():327-62. PubMed ID: 27418070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia.
    Holt DJ; Herman MM; Hyde TM; Kleinman JE; Sinton CM; German DC; Hersh LB; Graybiel AM; Saper CB
    Neuroscience; 1999; 94(1):21-31. PubMed ID: 10613493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice.
    Crochemore C; Peña-Altamira E; Virgili M; Monti B; Contestabile A
    Neurochem Int; 2005 Apr; 46(5):357-68. PubMed ID: 15737434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of presumed cholinergic mesopontine tegmental neurons by acetylcholine and monoamines applied iontophoretically in unanesthetized cats.
    Koyama Y; Sakai K
    Neuroscience; 2000; 96(4):723-33. PubMed ID: 10727790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of in vivo microdialysis to the study of cholinergic systems.
    Day JC; Kornecook TJ; Quirion R
    Methods; 2001 Jan; 23(1):21-39. PubMed ID: 11162147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of the cholinergic system in the brain during aging and in Alzheimer's disease.
    Schliebs R; Arendt T
    J Neural Transm (Vienna); 2006 Nov; 113(11):1625-44. PubMed ID: 17039298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the cholinergic system in the pathology and treatment of schizophrenia.
    Scarr E; Dean B
    Expert Rev Neurother; 2009 Jan; 9(1):73-86. PubMed ID: 19102670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area.
    Forster GL; Blaha CD
    Eur J Neurosci; 2000 Oct; 12(10):3596-604. PubMed ID: 11029630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia as a disorder of neuroplasticity.
    McCullumsmith RE; Clinton SM; Meador-Woodruff JH
    Int Rev Neurobiol; 2004; 59():19-45. PubMed ID: 15006483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.